Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methamphetamine-related cardiovascular diseases.

Valentin Schwarzbach1, Karsten Lenk1, Ulrich Laufs1

  • 1Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany.

ESC Heart Failure
|January 18, 2020
PubMed
Summary

Crystal methamphetamine abuse significantly harms the cardiovascular system, leading to serious conditions like heart attacks and strokes. Long-term use and relapse are key challenges in treating methamphetamine-induced cardiomyopathy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-invasive vessel fractional flow reserve versus fractional flow reserve guidance to revascularize intermediate coronary stenosis (LIPSIA-STRATEGY) trial: study protocol for a randomized controlled trial.

Trials·2026
Same author

Development and application of a structured preclinical protocol for MRI-guided endomyocardial biopsy: a multimodal imaging approach using a hybrid vessel phantom and porcine in vivo models.

Zeitschrift fur medizinische Physik·2026
Same author

How can common errors in left heart echocardiography be avoided? An expert proposalby the German Working Group of Cardiovascular Ultrasound.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Effect of Cardiac Arrest Center Protocol Implementation on Survival After Nontraumatic Out-of-Hospital Cardiac Arrest.

Journal of the American Heart Association·2025
Same author

Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial.

Lancet (London, England)·2024
Same author

The Diagnosis and Treatment of Hypertrophic Cardiomyopathy.

Deutsches Arzteblatt international·2024

Area of Science:

  • Cardiology
  • Toxicology
  • Public Health

Background:

  • Crystal methamphetamine (MA) abuse is a growing global health concern.
  • MA affects the central nervous system, causing euphoria and alertness, but also psychiatric and gastrointestinal issues.
  • Cardiovascular complications are a major cause of morbidity and mortality in MA users.

Observation:

  • MA consumption is linked to hypertension, myocardial toxicity, stroke, coronary artery disease, and sudden cardiac death.
  • Elevated catecholamine levels in the synaptic gap are implicated in MA's cardiovascular effects.
  • The duration of MA use is a critical factor influencing patient prognosis.

Findings:

  • MA abuse leads to a spectrum of cardiovascular damage, including acute and chronic myocardial toxicity.
Keywords:
CardiomyopathyCrystalEuropeHeart failureMethamphetamine

Related Experiment Videos

  • Catecholamine-mediated pathologies are significant contributors to MA-induced cardiovascular complications.
  • Understanding the pathophysiology of MA-related cardiomyopathy requires further research.
  • Implications:

    • Increased awareness of cardiac complications in MA users is crucial for timely intervention.
    • Drug abstinence is the primary treatment, with cardiac complications managed per established guidelines.
    • Treatment success is challenged by patient non-compliance and frequent relapses, necessitating improved therapeutic strategies.